Tom MacRury
- Efficacy of a novel SHIP1 activator in animals and healthy human volunteers exposed to inhaled lipopolysaccharideBy David Chernoff, Patrick Tam, Lloyd Mackenzie, Judy Toews, Grant Stenton, Curtis Harwig, Jeffrey Raymond, Vanessa Brown, Stephen Smith, Stuart Elborn, Csaba Szabo and Tom MacRuryDavid Chernoff1Clinical Development, Aquinox Pharmaceuticals, Richmond, BC, CanadaPatrick Tam1Clinical Development, Aquinox Pharmaceuticals, Richmond, BC, CanadaLloyd Mackenzie1Clinical Development, Aquinox Pharmaceuticals, Richmond, BC, CanadaJudy Toews1Clinical Development, Aquinox Pharmaceuticals, Richmond, BC, CanadaGrant Stenton1Clinical Development, Aquinox Pharmaceuticals, Richmond, BC, CanadaCurtis Harwig1Clinical Development, Aquinox Pharmaceuticals, Richmond, BC, CanadaJeffrey Raymond1Clinical Development, Aquinox Pharmaceuticals, Richmond, BC, CanadaVanessa Brown2Respiratory Medicine Group, Queen's University of Belfast, Northern Ireland, United KingdomStephen Smith3Clinical Development, Celerion, Belfast, Northern Ireland, United KingdomStuart Elborn2Respiratory Medicine Group, Queen's University of Belfast, Northern Ireland, United KingdomCsaba Szabo1Clinical Development, Aquinox Pharmaceuticals, Richmond, BC, CanadaTom MacRury1Clinical Development, Aquinox Pharmaceuticals, Richmond, BC, Canada
- The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthmaBy Brian Leaker, Brian O'Connor, Peter Barnes, Lloyd Mckenzie, David Chernoff, Judith Neville, Pat Tam, Grant Stenton, Curtis Harwig and Tom MacRuryBrian Leaker1Respiratory Clinical Trials Ltd, 18-22 Queen Anne St, London, United KingdomBrian O'Connor1Respiratory Clinical Trials Ltd, 18-22 Queen Anne St, London, United KingdomPeter Barnes2Thoracic Medicine, National Heart and Lung Institute, London, United KingdomLloyd Mckenzie3Aquinox Pharmaceuticals Inc, Aqunionx Pharmaceuticals Inc, Vancouver, CanadaDavid Chernoff3Aquinox Pharmaceuticals Inc, Aqunionx Pharmaceuticals Inc, Vancouver, CanadaJudith Neville3Aquinox Pharmaceuticals Inc, Aqunionx Pharmaceuticals Inc, Vancouver, CanadaPat Tam3Aquinox Pharmaceuticals Inc, Aqunionx Pharmaceuticals Inc, Vancouver, CanadaGrant Stenton3Aquinox Pharmaceuticals Inc, Aqunionx Pharmaceuticals Inc, Vancouver, CanadaCurtis Harwig3Aquinox Pharmaceuticals Inc, Aqunionx Pharmaceuticals Inc, Vancouver, CanadaTom MacRury3Aquinox Pharmaceuticals Inc, Aqunionx Pharmaceuticals Inc, Vancouver, Canada
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.